Adding Sodium–Glucose Co-Transporter 2 Inhibitors to Sulfonylureas and Risk of Hypoglycemia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

BACKGROUND: Hypoglycemia is an important event that could be related to increased mortality in patients with diabetes. The risk of hypoglycemia is not clearly illustrated to increase when Sodiumglucose co-transporter 2 (SGLT-2) inhibitors are used concomitantly with sulfonylureas. The present study...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Meng, Liu, Qiaoshu, Jiang, Tiejian, Nizigiyimana, Paul, Lei, Minxiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8568344/
https://www.ncbi.nlm.nih.gov/pubmed/34744998
http://dx.doi.org/10.3389/fendo.2021.713192

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8568344/
https://www.ncbi.nlm.nih.gov/pubmed/34744998
http://dx.doi.org/10.3389/fendo.2021.713192

Ejemplares similares